Procalcitonin-guided therapy in severe sepsis and septic shock
- PMID: 25033407
- PMCID: PMC4057232
- DOI: 10.1186/cc13856
Procalcitonin-guided therapy in severe sepsis and septic shock
Comment in
-
Procalcitonin-guided therapy in severe sepsis and septic shock. Authors' response.Crit Care. 2014 May 3;18(3):427. Crit Care. 2014. PMID: 25473656 No abstract available.
Comment on
-
Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.Crit Care. 2013 Dec 11;17(6):R291. doi: 10.1186/cc13157. Crit Care. 2013. PMID: 24330744 Free PMC article.
References
-
- Deliberato RO, Marra AR, Sanches PR, Martino MD, Ferreira CE, Pasternak J, Paes AT, Pinto LM, dos Santos OF, Edmond MB. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis. 2013;76:266–271. doi: 10.1016/j.diagmicrobio.2013.03.027. - DOI - PubMed
-
- Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, Collado J, García-Labattut A, Carriedo D, Valledor M, De Frutos M, López MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J. Grupo de Estudios y Análisis en Cuidados Intensivos. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008;12:R158. doi: 10.1186/cc7157. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
